VNDA
#3265
Vanda Pharmaceuticals Inc. - Common Stock
5.2 9 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.76%
Changement Mensuel
+2.52%
Evolution sur 6 mois
-38.91%
Changement Annuel
-4.34%
Clôture Précédente
5.4 4
Open
5.2 9
Low
5.2 9
High
5.2 9
Volume
67
Financials
- Market Capitalization 319.85 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.36
ratio cours/chiffre d'affaires
2.41
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3222 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +6.17% | +36.16% | 336.28 M USD | ||
| 3260 |  IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | -4.22% | -5.67% | +16.59% | -11.52% | 322.84 M USD | ||
| 3293 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +30.40% | +92.22% | 311.95 M USD | ||
| 3307 |  IRD Opus Genetics, Inc. - Common Stock | 3.69 USD | -4.16% | -8.21% | -4.16% | -0.81% | 306.99 M USD |